Phase 4 N=21 Effect of Probiotic Supplementation on Endothelial Function
Coronary Artery Disease
Primary: Brachial Artery Flow Mediated Dilation — 1.2 percent change
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=40 Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Kidney Transplantation
Primary: Incidence of Acute Rejection (Banff '97) or Antibody Mediated Rejection — 2; 0; 5; 3 participants
Phase 4 N=2,262 EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
Coronary Artery Disease
Primary: Percentage of Participants With Composite of All Death, Target Vessel Myocardial Infarction (MI) and Stroke (Defined as MACCE) for Randomized Subjects — 4.3; 4.8; 16.9…
Phase 4 N=75 Unicirc vs Open Surgical Circumcision
Circumcision, Male
Primary: Time Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound Dressing — 12; 25 Minutes
Phase 4 N=6,661 A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Hepatitis C, Chronic
Primary: Number of Participants With Non-Serious Adverse Events (AEs) And Serious Adverse Events (SAEs) — 2058; 67 Participants
Phase 4 N=88 Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients
Chronic Obstructive Pulmonary Disease · COPD
Primary: Forced Expiratory Volume in One Second (FEV1) at 1 h Post-inhalation — 1.676; 1.595 Liters — p=0.0017
Phase 4 N=89 The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Glaucoma · Application Site Pigmentation Changes
Primary: The Extent of Latanoprost, Bimatoprost and Travoprost Induced Periocular Skin Hyperpigmentation Over a One Year Time Course in Newly Diagnosed Primary Open Angle and…
Phase 4 N=124 Moxifloxacin vs. Polytrim for Conjunctivitis
Conjunctivitis
Primary: Number of Participants With Normal Physical Examination of the Eye — 49; 37 participants
Phase 4 N=102 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)
Rhinitis, Allergic, Seasonal
Primary: Percentage of Participants Who Experienced at Least One Event of Local Swelling — 13.7; 21.6; 14.7 Percentage of Participants
Phase 4 N=60 TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy
Acute Pain
Primary: Post Operative Opioid Use — 24.9; 51.7 micrograms of fentanyl equivalents
Phase 4 N=20 Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
Epilepsy · Contraception
Primary: Percent of Participants That Experienced Clinically Meaningful Change in Lamotrigine Level — 0 percentage of participants
Phase 4 N=48 Effects of Intravenous Lidocaine Associated With Magnesium Sulfate on the Cisatracurium-Induced Neuromuscular Block
Neuromuscular Block
Primary: Latency — 139.70; 151.30; 147.80 seconds — p=0.9651
Phase 4 N=11,679 SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Asthma
Primary: Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal…
Phase 4 N=38 Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
Chronic Kidney Disease
Primary: Serum Phosphorus Levels — 4.6; 4.6 mg/dL
Phase 4 N=386 The Study of Soy Isoflavones in Asthma
Asthma
Primary: Mean Change From Baseline to 24 Weeks for FEV1 — -0.001; 0.03 Liters